Cargando…

Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment

AIMS: Left atrium (LA) dilation is associated with adverse cardiovascular (CV) outcomes. Blood stasis, thrombus formation and atrial fibrillation may occur, especially in heart failure (HF) patients. It is not known whether preventive antithrombotic treatment may decrease the incidence of CV events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Tullio, Marco R., Qian, Min, Thompson, John L.P., Labovitz, Arthur J., Mann, Douglas L., Sacco, Ralph L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Graham, Susan, Lip, Gregory Y.H., Levin, Bruce, Mohr, Jay P., Buchsbaum, Richard, Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Homma, Shunichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165930/ https://www.ncbi.nlm.nih.gov/pubmed/30015405 http://dx.doi.org/10.1002/ehf2.12331

Ejemplares similares

Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
por: Graham, Susan, et al.
Publicado: (2014)

Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial
por: Lee, Tetz C., et al.
Publicado: (2019)

Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trial
por: Ito, Kazato, et al.
Publicado: (2021)

Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial
por: Matsumoto, Kenji, et al.
Publicado: (2020)

Antithrombotic therapy in chronic liver disease: to clot or not to clot
por: Calvert, Peter, et al.
Publicado: (2021)

Systolic time intervals in patients with heart failure: time to teach new dogs old tricks
por: Njoroge, Joyce N., et al.
Publicado: (2020)

Intracerebral Hemorrhage and Exposure to Antithrombotic Drugs
por: Nielsen, Peter Brønnum, et al.
Publicado: (2021)

Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis
por: Ivany, Elena, et al.
Publicado: (2022)

Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort
por: Huisman, Menno V., et al.
Publicado: (2016)

Efficacy and safety of triple versus dual antithrombotic therapy in atrial fibrillation and ischemic heart disease: a systematic review and meta-analysis
por: Zhu, Wengen, et al.
Publicado: (2017)

Association of Blood Pressure Control Level With Left Ventricular Morphology and Function and With Subclinical Cerebrovascular Disease
por: Nakanishi, Koki, et al.
Publicado: (2017)

Moderate alcohol consumption is associated with better endothelial function: a cross sectional study
por: Suzuki, Keiko, et al.
Publicado: (2009)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF
por: Kozieł, Monika, et al.
Publicado: (2021)

Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization
por: Dreijer, Albert R., et al.
Publicado: (2020)

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021)

Realidad y leyenda de Pancho Villa
por: Estol, Horacio
Publicado: (1956)

Marine Antithrombotics
por: Dwivedi, Rohini, et al.
Publicado: (2020)

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry: Trends in antithrombotic therapy use in China
por: Liu, Xiaoxia, et al.
Publicado: (2023)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
por: Mazurek, Michał, et al.
Publicado: (2017)

Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature
por: Radu, Razvan I., et al.
Publicado: (2021)

Introducing ASE's Critical Care Echocardiography (CCE) Specialty Interest Group!
por: Labovitz, Arthur J.
Publicado: (2020)

Endothelial dysfunction is associated with carotid plaque: a cross-sectional study from the population based Northern Manhattan Study
por: Rundek, Tatjana, et al.
Publicado: (2006)

Relationship Between Body Mass and Ambulatory Blood Pressure: Comparison with Office Blood Pressure Measurement and Effect of Treatment
por: Baird, Stacy W., et al.
Publicado: (2017)

Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010)

Antithrombotics in heart failure
por: Miličić, Davor, et al.
Publicado: (2014)

Antithrombotic therapy in TAVI
por: Vavuranakis, Manolis, et al.
Publicado: (2018)

Antithrombotic Agents and Cancer
por: Bruno, Annalisa, et al.
Publicado: (2018)

Monitoring of Antithrombotic Therapy
por: Yamazaki, Masako
Publicado: (2020)

Mosquito-Derived Anophelin Sulfoproteins Are Potent Antithrombotics
por: Watson, Emma E., et al.
Publicado: (2018)

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
por: Beier, Lea, et al.
Publicado: (2022)

Antithrombotic stewardship: a multidisciplinary team approach towards improving antithrombotic therapy outcomes during and after hospitalisation: a study protocol
por: Dreijer, Albert R, et al.
Publicado: (2016)

Unravelling the Distinct Effects of Systolic and Diastolic Blood Pressure Using Mendelian Randomisation
por: Le, Nhu Ngoc, et al.
Publicado: (2022)

Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS Trial
por: Del Brutto, Victor J., et al.
Publicado: (2022)

Health locus of control and the sense of self-efficacy in patients with systolic heart failure: a pilot study
por: Rydlewska, Agnieszka, et al.
Publicado: (2013)

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
por: Staerk, Laila, et al.
Publicado: (2015)

Induction of Day-Time Periodic Breathing is Associated With Augmented Reflex Response From Peripheral Chemoreceptors in Male Patients With Systolic Heart Failure
por: Niewinski, Piotr, et al.
Publicado: (2022)

Pathophysiological Changes in the Hemostatic System and Antithrombotic Management in Kidney Transplant Recipients
por: van den Berg, Tamar A.J., et al.
Publicado: (2023)

Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome
por: Arachchillage, Deepa J., et al.
Publicado: (2023)

The effect of hospital-based antithrombotic stewardship on adherence to anticoagulant guidelines
por: Dreijer, Albert R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0q6essunji0k037ipnb6f5i48m